Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,847 Skin Cancer
clinical trials

Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sylvania, OH
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Syracuse, NY
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tawas City, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Truckee, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
West Covina, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/KEYNOTE-054)
Status: Enrolling, Phase III
Updated: 8/10/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Morristown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Solid Tumors Habouring NTRK Fusion Clinical Trial
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Guangzhou,
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety Study of MGD009 in B7-H3-expressing Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Camperdown,
Click here to add this to my saved trials
Uveal Melanoma Clinical Trial
A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Westmead,
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Murray, UT
Click here to add this to my saved trials
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial Clinical Trial
Registry Study for Talimogene Laherparepvec
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Melanoma, Ocular Clinical Trial
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Garden City, KS
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Great Bend, KS
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Monticello, MN
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Newburgh, IN
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ontario, OR
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Riverton, UT
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Desmoplastic Melanoma Clinical Trial
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Zanesville, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Charleston, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Coffeyville, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fosston, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Martinsburg, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Nampa, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
'Aiea, HI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ashland, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlingame, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Caro, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, MS
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dearborn, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Decatur, IL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fremont, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Georgetown, SC
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Great Bend, KS
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Henderson, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Honolulu, HI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Livonia, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
London, KY
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Monticello, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Newburgh, IN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Novi, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ontario, OR
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Pahrump, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Port Huron, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Pottstown, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rio Rancho, NM
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Riverton, UT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Rafael, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sandstone, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Youngstown, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Zanesville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study in Subjects With Small Primary Choroidal Melanoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Oncology Clinical Trial
CD40 Agonistic Antibody APX005M in Combination With Nivolumab
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Lake City, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Summit, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
1 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68